Study of RYZ101 in Combination with SoC in Subjects with SSTR+ ES-SCLC

Recruiting

Phase 1

RYZ101 & SoCStudy of RYZ101 in Combination with SoC in Subjects with SSTR+ ES-SCLC

Sponsor:

RayzeBio, Inc.

Code:

NCT05595460

Conditions

SCLC,Extensive Stage

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101 Dose Level 1

RYZ101 Dose Level 2

RYZ101 Dose Level 3

RYZ101 Dose Level -1

Atezolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by RayzeBio, Inc. on 2025-03-24.